JP2013523694A - 局所麻酔薬の生体接着性組成物 - Google Patents

局所麻酔薬の生体接着性組成物 Download PDF

Info

Publication number
JP2013523694A
JP2013523694A JP2013501854A JP2013501854A JP2013523694A JP 2013523694 A JP2013523694 A JP 2013523694A JP 2013501854 A JP2013501854 A JP 2013501854A JP 2013501854 A JP2013501854 A JP 2013501854A JP 2013523694 A JP2013523694 A JP 2013523694A
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
weight
composition according
amount
local anesthetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013501854A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013523694A5 (https=
Inventor
スンドベリ，マルク
ブローディン，アルネ
グスタヴソン，ヨナス
Original Assignee
ファーマネスト・エイビイ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44278867&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP2013523694(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by ファーマネスト・エイビイ filed Critical ファーマネスト・エイビイ
Publication of JP2013523694A publication Critical patent/JP2013523694A/ja
Publication of JP2013523694A5 publication Critical patent/JP2013523694A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/04—Heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Anesthesiology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2013501854A 2010-04-01 2011-03-31 局所麻酔薬の生体接着性組成物 Pending JP2013523694A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
SE1050322-5 2010-04-01
SE1050322 2010-04-01
US32542510P 2010-04-19 2010-04-19
US61/325,425 2010-04-19
PCT/EP2011/055025 WO2011121082A1 (en) 2010-04-01 2011-03-31 Bioadhesive compositions of local anaesthetics

Publications (2)

Publication Number Publication Date
JP2013523694A true JP2013523694A (ja) 2013-06-17
JP2013523694A5 JP2013523694A5 (https=) 2014-05-22

Family

ID=44278867

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013501854A Pending JP2013523694A (ja) 2010-04-01 2011-03-31 局所麻酔薬の生体接着性組成物

Country Status (17)

Country Link
US (1) US20130079371A1 (https=)
EP (1) EP2552409A1 (https=)
JP (1) JP2013523694A (https=)
KR (1) KR20130080435A (https=)
CN (1) CN102869344A (https=)
AU (1) AU2011234415C1 (https=)
BR (1) BR112012024885A2 (https=)
CA (1) CA2794280A1 (https=)
CL (1) CL2012002705A1 (https=)
EA (1) EA201290790A1 (https=)
IL (1) IL222225A0 (https=)
MX (1) MX2012011261A (https=)
NZ (1) NZ602540A (https=)
PH (1) PH12012501887A1 (https=)
SG (1) SG184072A1 (https=)
WO (1) WO2011121082A1 (https=)
ZA (1) ZA201206989B (https=)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017082121A1 (ja) 2015-11-12 2017-05-18 テルモ株式会社 徐放性局所投与剤
US10517859B2 (en) 2015-03-25 2019-12-31 Terumo Kabushiki Kaisha Gel local anesthetic agent and gel local anesthetic preparation using same
JP2020519635A (ja) * 2017-05-08 2020-07-02 アリヴィオ セラピューティクス， インコーポレイテッド 増大した薬剤負荷および接着のためのナノ構造化ゲルの製剤

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9642912B2 (en) 2006-03-06 2017-05-09 Crescita Therapeutics Inc. Topical formulations for treating skin conditions
US9308181B2 (en) 2006-03-06 2016-04-12 Nuvo Research Inc. Topical formulations, systems and methods
WO2010033726A2 (en) 2008-09-17 2010-03-25 The Brigham And Women's Hospital, Inc. Drug delivery composition comprising a self-assembled gelator
JP2013540757A (ja) 2010-09-24 2013-11-07 ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッド カプセル化された作用物質の放出を制御する能力を有するナノ構造ゲル
JP6363115B2 (ja) * 2013-02-28 2018-07-25 ミラ ファーマ コーポレイション 注射可能局所麻酔半固体製剤およびその組成物
US10220093B2 (en) 2013-02-28 2019-03-05 Mira Pharma Corporation Long-acting semi-solid lipid formulations
GB201317718D0 (en) * 2013-10-07 2013-11-20 Buzzz Pharmaceuticals Ltd Novel formulation
WO2018144991A1 (en) 2017-02-03 2018-08-09 The Brigham And Women's Hospital, Inc. Self-assembled gels formed with anti-retroviral drugs, prodrugs thereof, and pharmaceutical uses thereof
US10561606B2 (en) 2017-12-06 2020-02-18 Mira Pharma Corporation Injectable long-acting local anesthetic semi-solid gel formulations
EP3720420B1 (en) 2017-12-06 2025-08-27 HuZhou Hui Zhong Ji Shi Biotechnology Co., Ltd. Injectable long-acting local anesthetic semi-solid gel formulations
US11426418B2 (en) 2017-12-06 2022-08-30 Mira Pharma Corporation Injectable long-acting semi-solid gel formulations
CA3113948A1 (en) 2018-10-11 2020-04-16 Alivio Therapeutics, Inc. Non-injectable hydrogel formulations for smart release
EP4284272A4 (en) * 2021-01-29 2024-12-25 Insitu Biologics, Inc. COMPOSITIONS AND METHODS OF SUSTAINED TREATMENT OF PAIN
CN118697692B (zh) * 2024-06-27 2024-11-26 山东中医药大学附属医院 一种防苦麻醉胶浆剂、方法及应用
CN119587525B (zh) * 2024-11-07 2025-09-05 海南三帝制药有限公司 一种二甲卡因复合制剂及其制备方法

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01156919A (ja) * 1987-06-24 1989-06-20 Fujisawa Pharmaceut Co Ltd 経皮吸収用製剤
JPH09510980A (ja) * 1994-03-30 1997-11-04 デュメックス―アルファルマ エイ／エス 生物付着性物質としての脂肪酸エステルの使用
JP2008100939A (ja) * 2006-10-18 2008-05-01 Nichiban Co Ltd 皮膚刺激の少ない経皮吸収型製剤
JP2008526934A (ja) * 2005-01-14 2008-07-24 カムルス エービー ＧｎＲＨ類似体製剤
JP2009518374A (ja) * 2005-12-07 2009-05-07 ファーマコデックス リミテッド 活性薬剤、特にジクロフェナクの経皮投与
JP2009537513A (ja) * 2006-05-16 2009-10-29 マクニール アーベー トロメタモールを緩衝性作用物質として含有する、ニコチンの口腔内送り込み用薬用製品

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9601421D0 (sv) * 1996-04-12 1996-04-12 Astra Ab New composition
PL332724A1 (en) * 1996-10-14 1999-10-11 Kowa Co Local anaesthetic for extracorporeal use
US20040001889A1 (en) * 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
WO2004071398A2 (en) * 2003-02-17 2004-08-26 Cipla Ltd Pharmaceutical patch
US20050084508A1 (en) 2003-07-22 2005-04-21 Vancaillie Thierry G. Topical anesthesia formulation for bodily cavities
JP4931369B2 (ja) 2005-05-31 2012-05-16 ポーラ化成工業株式会社 リポソームおよびそれを含む処置用の組成物
MX2008004094A (es) * 2005-09-27 2009-02-27 Efrat Biopolymers Ltd Composiciones de polimero inyectables hidrofobicas, gelificantes.
US20070280972A1 (en) * 2006-04-25 2007-12-06 Zars, Inc. Adhesive solid gel-forming formulations for dermal drug delivery
US9918934B2 (en) 2006-12-12 2018-03-20 Edgar Joel Acosta-Zara Linker-based lecithin microemulsion delivery vehicles
US20090247494A1 (en) 2008-04-01 2009-10-01 Phillip Mark Kofsky Omega-3 essential fatty acid composition and method for treatment of anal and colon-rectal disorders

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01156919A (ja) * 1987-06-24 1989-06-20 Fujisawa Pharmaceut Co Ltd 経皮吸収用製剤
JPH09510980A (ja) * 1994-03-30 1997-11-04 デュメックス―アルファルマ エイ／エス 生物付着性物質としての脂肪酸エステルの使用
JP2008526934A (ja) * 2005-01-14 2008-07-24 カムルス エービー ＧｎＲＨ類似体製剤
JP2009518374A (ja) * 2005-12-07 2009-05-07 ファーマコデックス リミテッド 活性薬剤、特にジクロフェナクの経皮投与
JP2009537513A (ja) * 2006-05-16 2009-10-29 マクニール アーベー トロメタモールを緩衝性作用物質として含有する、ニコチンの口腔内送り込み用薬用製品
JP2008100939A (ja) * 2006-10-18 2008-05-01 Nichiban Co Ltd 皮膚刺激の少ない経皮吸収型製剤

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10517859B2 (en) 2015-03-25 2019-12-31 Terumo Kabushiki Kaisha Gel local anesthetic agent and gel local anesthetic preparation using same
WO2017082121A1 (ja) 2015-11-12 2017-05-18 テルモ株式会社 徐放性局所投与剤
JP2020519635A (ja) * 2017-05-08 2020-07-02 アリヴィオ セラピューティクス， インコーポレイテッド 増大した薬剤負荷および接着のためのナノ構造化ゲルの製剤
JP2022103299A (ja) * 2017-05-08 2022-07-07 アリヴィオ セラピューティクス， インコーポレイテッド 増大した薬剤負荷および接着のためのナノ構造化ゲルの製剤
JP7211974B2 (ja) 2017-05-08 2023-01-24 アリヴィオ セラピューティクス， インコーポレイテッド 増大した薬剤負荷および接着のためのナノ構造化ゲルの製剤
JP2023041861A (ja) * 2017-05-08 2023-03-24 アリヴィオ セラピューティクス， インコーポレイテッド 増大した薬剤負荷および接着のためのナノ構造化ゲルの製剤

Also Published As

Publication number Publication date
ZA201206989B (en) 2014-04-30
BR112012024885A2 (pt) 2016-06-21
AU2011234415A1 (en) 2012-10-18
CA2794280A1 (en) 2011-10-06
PH12012501887A1 (en) 2012-12-17
SG184072A1 (en) 2012-10-30
AU2011234415B2 (en) 2014-04-10
EA201290790A1 (ru) 2013-04-30
IL222225A0 (en) 2012-12-31
AU2011234415C1 (en) 2014-07-10
WO2011121082A1 (en) 2011-10-06
EP2552409A1 (en) 2013-02-06
NZ602540A (en) 2014-05-30
KR20130080435A (ko) 2013-07-12
MX2012011261A (es) 2012-12-05
CL2012002705A1 (es) 2013-02-01
US20130079371A1 (en) 2013-03-28
CN102869344A (zh) 2013-01-09

Similar Documents

Publication Publication Date Title
JP2013523694A (ja) 局所麻酔薬の生体接着性組成物
JP5972862B2 (ja) 熱ゲル化麻酔組成物
CN102892408A (zh) 适于局部麻醉剂的无水药物组合物
JP2013119528A (ja) 非水性貼付剤
JP4500013B2 (ja) 局所麻酔組成物
JP2023092097A (ja) 非水系貼付剤およびその製造方法
KR102745034B1 (ko) 수분 감응성 졸-겔 상전이 기반 유착방지용 조성물
WO2026083220A1 (en) Cidofovir lipid based topical gel formulation
JP2021080170A (ja) 非水系貼付剤
JP2024519493A (ja) 局所ナプロキセン製剤及びそれらの使用
CN114302707A (zh) 局部阿昔洛韦制剂及其用途

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140331

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20140331

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20141114

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20141118

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20150218

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20150721